FDA panel debates booster for single-dose vaccine

U.S. health advisers are meeting to tackle who needs boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when. J&J wants its vaccine recipients to be eligible for another shot, citing increased protection after a second dose. (Oct. 15)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting